| Subject: | FDA Approves New Treatment for Back Pain |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 5 Nov 2004 - 10:00 am |
| The FDA has published approval notification for the use of an artificial spinal disc called the Charité, manufactured by DePuy Spine, Inc. The artificial disc is to replace the patient's own diseased or damaged intervertebral disc. The Charité artificial disc offers a surgical option to lumbar fusion procedures and has been approved for use in patients who have Degenerative Disc Disease of the lumbar spine (from L4-S1) and who have had no relief from low back pain after at least six months of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
Related MCN Products:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
